Skip to main content

Introduction: The Practice of Pharmacotherapy

  • Chapter
  • 63 Accesses

Abstract

Experimentation with drugs that alter mood, thinking, or perception represents a timeless human enterprise. Although largely aimed at the relief of suffering, the utilization of various pharmacological agents also reflects different cultural, religious, and political ideologies. Frequently, implementing effective pharmacological treatments depends more on social issues, economic considerations, and serendipity than on clinical factors. A historical account of the discovery and introduction of psychoactive drugs in the United States highlights these patterns.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sen G., Bose K. C.: Rauwolfia serpentina, a new Indian drug for insanity and high blood pressure. Indian Med World 2:194–201, 1931.

    Google Scholar 

  2. Laborit H., Huguenard P., Alluaume R.: Un nouveau stabilisateur vegetatif, le 4560 RP. Presse Med 60:206–208, 1952.

    PubMed  CAS  Google Scholar 

  3. Lehmann H. E., Hunrahan G. E.: Chlorpromazine, a new inhibiting agent for psychomotor excitement and manic states. Arch Neurol Psychiatry 71:227–237, 1954.

    Article  CAS  Google Scholar 

  4. Cade J. F. J.: Lithium salts in the treatment of psychotic excitement. Med J Aust 2:349–352. 1949.

    PubMed  CAS  Google Scholar 

  5. Sternback L. H., Randall L. O., Gustafson, S. R.: 1,4-Benzodiazepines: Chlordiazepoxide and related compounds, in Gordon M. (ed): Psychopharmacological Agents. New York, Academic Press, 1964, vol 1, 137–224.

    Google Scholar 

  6. Kuhn R.: The treatment of depressive states with G22355 (imipramine hydrochloride). Am J Psychiatry 115:459–464, 1958.

    PubMed  CAS  Google Scholar 

  7. Group for the Advancement of Psychiatry: Pharmacotherapy and Psychotherapy: Paradoxes, Problems and Progress, report 93. New York, Group for the Advancement of Psychiatry, 1975, vol 9.

    Google Scholar 

  8. Weissman M. M.: The psychological treatment of depression: Evidence for the efficacy of psychotherapy done in comparison with, and in combination with, pharmacotherapy. Arch Gen Psychiatry 36:1261–1269, 1979.

    Article  PubMed  CAS  Google Scholar 

  9. Beck A. T., Rush A. J., Shaw B. F., et al: Cognitive Therapy of Depression. New York, Guilford Press, 1979.

    Google Scholar 

  10. Gelenberg A. J.: New perceptions on the use of tricyclic antidepressants. J Clin Psychiatry 50:7(Suppl):3–10, 1989.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schoonover, S.C., Gelenberg, A.J. (1991). Introduction: The Practice of Pharmacotherapy. In: Gelenberg, A.J., Bassuk, E.L., Schoonover, S.C. (eds) The Practitioner’s Guide to Psychoactive Drugs. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1137-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1137-0_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1139-4

  • Online ISBN: 978-1-4757-1137-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics